CALOOCAN CITY, Aug. 14 (PIA) -- The Food and Drug Administration (FDA) said on Friday given a best case scenario, vaccine for COVID-19 can be approved by the end of 2020.
According to FDA Administrator Director-General Dr. Eric Domingo, their agency will not approve a COVID-19 vaccine unless it has completed all the required local procedures to ensure its safety and efficacy.
"Para talagang sigurado kailangan kang mag-clinical trial Phase 3. Ito 'yung maramihan na anywhere from mga 3,000. 'Yung ibang trials up to 30,000, and they complete those in 3 months pagkatapos maganda ang resulta, then 'yung best case scenario siguro a few of these vaccines might be applying for registration by the end of the year," he said.
The FDA reminded that the vaccine might have a side effect such as pain or swelling on the injected area, fever, allergy to the vaccine, diseases, or worse, death.
The possible effects of the vaccines being developed are strictly being monitored. The agency guaranteed that it will be thorough in its process and will disallow the use of a vaccine if it is not safe.
To recall, Malacanang said earlier the Philippines is set to conduct the Phase 3 of clinical trials of Russia's COVID-19 vaccine from October 2020 to March 2021. (PIA NCR)